Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serhat Sekmek

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Chemotherapy (Florence, Italy)|February 20, 2025
Pembrolizumab associated immune thrombocytopeniaPerihan Perkin, Serhat Sekmek, Dogan Bayram, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 11, 2023
Cabozantinib-induced heart failureSerhat Sekmek, Dogan Bayram, Gokhan Ucar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 14, 2024
Letrozole-induced reversible acute heart failureSerhat Sekmek, Dogan Bayram, Ismet Seven, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 13, 2024
The HALP score as a prognostic factor in metastatic biliary cancerİsmet Seven, İrfan Karahan, Fahriye Tuğba Köş, et al.
Injury|August 29, 2024
Osseous metastases of uterine leiomyosarcoma: Analysis of survival & surgical managementŞahin Çepni, Yasin Erdoğan, Enejd Veizi, et al.
International Urology and Nephrology|December 27, 2024
Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancersİsmet Seven, Selin Aktürk Esen, Serhat Sekmek, et al.
Expert Review of Anticancer Therapy|August 30, 2025
Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancerSerhat Sekmek, Serhat Ozan, Fahriye Tugba Kos, et al.
Anti-Cancer Drugs|December 23, 2025
Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivityUgur Ozberk, Selin Akturk Esen, Serhat Sekmek, et al.
Journal of Ovarian Research|June 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancerDerya Demirtaş Esmer, Emre Hafızoğlu, Murat Bardakçı, et al.
Transplantation Proceedings|July 18, 2021
Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant RecipientsSerhat Sekmek, Tolga Yildirim, Neriman Sila Koc, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Chemotherapy (Florence, Italy)|February 20, 2025
Pembrolizumab associated immune thrombocytopeniaPerihan Perkin, Serhat Sekmek, Dogan Bayram, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 11, 2023
Cabozantinib-induced heart failureSerhat Sekmek, Dogan Bayram, Gokhan Ucar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 14, 2024
Letrozole-induced reversible acute heart failureSerhat Sekmek, Dogan Bayram, Ismet Seven, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 13, 2024
The HALP score as a prognostic factor in metastatic biliary cancerİsmet Seven, İrfan Karahan, Fahriye Tuğba Köş, et al.
Injury|August 29, 2024
Osseous metastases of uterine leiomyosarcoma: Analysis of survival & surgical managementŞahin Çepni, Yasin Erdoğan, Enejd Veizi, et al.
International Urology and Nephrology|December 27, 2024
Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancersİsmet Seven, Selin Aktürk Esen, Serhat Sekmek, et al.
Expert Review of Anticancer Therapy|August 30, 2025
Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancerSerhat Sekmek, Serhat Ozan, Fahriye Tugba Kos, et al.
Anti-Cancer Drugs|December 23, 2025
Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivityUgur Ozberk, Selin Akturk Esen, Serhat Sekmek, et al.
Journal of Ovarian Research|June 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancerDerya Demirtaş Esmer, Emre Hafızoğlu, Murat Bardakçı, et al.
Transplantation Proceedings|July 18, 2021
Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant RecipientsSerhat Sekmek, Tolga Yildirim, Neriman Sila Koc, et al.
Pageof 4